Nanotechnology has been deployed in agriculture for years in nanoclays, cyclodextrans and nanoemulsions. Yet, nanotechnology promises to play a much greater role in agriculture. Platform nano-enabled targeted delivery, controlled release, and transfection platforms are experiencing significant spikes in research, development and commercialization in the pharmaceutical space which also represent a significant opportunity for cross-fertilization of innovation in the agriculture industry.

Join us for an evening to discuss convergence and networking opportunities among these sectors. 

This Nano&BioRoundtable^TM will feature both agricultural technology and pharmaceutical companies, including Liquidia and Novozymes, who will present about their own delivery systems or about a need for an innovative solution to enhance their technologies. Our showcase companies will be available for one on one interaction during the networking reception. 

Keynote Presentation:
Sandra Merkel-DeJames, Ph.D., Manager, Business Creation Biobusiness Development and Acquisitions, Novozymes

Showcase Company Presentations:

• Liquidia Technologies - Frank J. Malinoski, M.D., Ph.D., Chief Medical Officer
• PharmAgra Labs - Roger Frisbee, Co-President
• Piedmont Pharmaceuticals - Eric Barnett, MD, ACA, Executive Vice President, Business Development and Marketing
• Nanovector Inc. -  Albert D. Bender, Ph.D., CEO